Font Size:
a
A
A
Keyword [Receptor Tyrosine Kinase inhibitors]
Result: 41 - 50 | Page: 3 of 3
41.
Detection Of Prognostic Indicators And Survival Analysis In Patients With EGFR Mutant Lung Adenocarcinoma
42.
The Impact Of Cocurrent Alterations On EGFR-TKIs Efficacy And Progression Patterns After Drug Resistance In Advanced EGFR-mutant NSCLC Patients
43.
Treatment Of Advanced EGFR-mutant Non-small-cell Lung Cancer:A Single-center Experience
44.
Yi-Fei San-Jie Pill Reverses Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer By Modulating MET-associated MiR-335-5p
45.
Design,Synthesis And Biological Evaluation Ofindole Carboxamide Derivatives And Analogs
46.
The Design,Synthesis And Application Of The Fourth Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
47.
Efficacy And Safety Analyses Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Combined With Chemotherapy In Advanced Non–small-cell Lung Cancer With An EGFR/TP53 Co-mutation
48.
Comparative Efficacy And Safety Of First-line Treatments For Epidermal Growth Factor Receptor Mutation-positive Advanced Non-small Cell Lung Cancer
49.
Clinical Analysis Of Different Therapeutic Modes Of TKI Combined With SRS In The Treatment Of Lung Adenocarcinoma Patients With EGFR Sensitive Mutation And Primary Brain Metastasis
50.
Prognostic Analysis Of Adjuvant Targeted Therapy For EGFR-positive ⅠA Stage Invasive Lung Adenocarcinoma After Complete Resection
<<First
<Prev
Next>
Last>>
Jump to
